Aceto Moves Ahead With Rising Divestment
Aceto has received approval to divest its Rising Pharmaceuticals unit to Shore Suven Pharma for $15m as part of bankruptcy proceedings.
Aceto has received approval to divest its Rising Pharmaceuticals unit to Shore Suven Pharma for $15m as part of bankruptcy proceedings.